24970 Federal Register / Vol. 77, No. 81 / Thursday, April 26, 2012 / Notices 

concerning individuals associated with 

the grant applications, the disclosure of 

which would constitute a clearly 

unwarranted invasion of personal 

privacy. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; SBIR Topic 

255 Development of Anticancer Agents 

Meeting I. 

Date: May 14, 2012. 

Time: 12 p.m. to 3 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: National Institutes of Health, 6116 

Executive Boulevard, Room 611, Rockville, 

MD 20852, (Telephone Conference Call). 

Contact Person: Shakeel Ahmad, Ph.D., 

Scientific Review Officer, Research Programs 

Review Branch, Division of Extramural 

Activities, National Cancer Institute, NIH, 

6116 Executive Boulevard, Room 8139, 

Bethesda, MD 20892–8328, (301) 594–0114, 

ahmads@mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; SBIR Topic 

255 Development of Anticancer Agents 

Meeting II. 

Date: May 15, 2012. 

Time: 12 p.m. to 3 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: National Institutes of Health, 6116 

Executive Boulevard, Room 210, Rockville, 

MD 20852, (Telephone Conference Call). 

Contact Person: Virginia P. Wray, Ph.D., 

Deputy Chief, Research Programs Review 

Branch, Research Programs Review Branch, 

Division of Extramural Activities, National 

Cancer Institute, NIH, 6116 Executive Blvd., 

Room 8125, Bethesda, MD 20892–8328, 301– 

496–9236, wrayv@mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; SPORE in 

Breast, Prostate and Thyroid Cancers. 

Date: May 23–24, 2012. 

Time: 8 a.m. to 1 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Bethesda North Marriott Hotel & 

Conference Center, Montgomery County 

Conference Center Facility, 5701 Marinelli 

Road, North Bethesda, MD 20852. 

Contact Person: Wlodek Lopaczynski, MD, 

Ph.D., Scientific Review Officer, Research 

Programs Review Branch, Division of 

Extramural Activities, National Cancer 

Institute, NIH, 6116 Executive Blvd., Room 

8131, Bethesda, MD 20892, 301–594–1402, 

lopacw@mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; NCI 

Program Project Review Panel Meeting IV. 

Date: June 11–12, 2012. 

Time: 3 p.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hilton Washington/Rockville, 1750 

Rockville Pike, Rockville, MD 20852. 

Contact Person: Majed M. Hamawy, Ph.D., 

Scientific Review Officer, Research Programs 

Review Branch, Division of Extramural 

Activities, National Cancer Institute, NIH, 

6116 Executive Boulevard, Room 8135, 

Bethesda, MD 20892, 301–594–5659, 

mh101v@nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; NCI 

Program Project Review Panel Meeting II. 

Date: June 13–14, 2012. 

Time: 8 a.m. to 1 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Doubletree Hotel Bethesda, 

(Formerly Holiday Inn Select), 8120 

Wisconsin Avenue, Bethesda, MD 20814. 

Contact Person: Delia Tang, MD, Scientific 

Review Officer, Research Programs Review 

Branch, Division of Extramural Activities, 

National Cancer Institute, NIH, 6116 

Executive Blvd., Room 8123, Bethesda, MD 

20892, 301–496–2330, tangd@mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; NCI 

Program Project Review Panel Meeting I. 

Date: June 14–15, 2012. 

Time: 8 a.m. to 11 a.m. 

Agenda: To review and evaluate grant 

applications. 

Place: DoubleTree Hotel and Executive 

Meeting Center; 8120 Wisconsin Ave., 

Bethesda, MD 20814. 

Contact Person: David G. Ransom, Ph.D., 

Scientific Review Officer, Research Programs 

Review Branch, Division of Extramural 

Activities, National Cancer Institute, NIH, 

6116 Executive Blvd., Room 8133, Bethesda, 

MD 20892–8328, 301–451–4757, 

david.ransom@nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; Small 

Grants Program for Cancer Epidemiology. 

Date: June 21–22, 2012. 

Time: 8:30 a.m. to 5:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hilton Washington/Rockville, 1750 

Rockville Pike, Rockville, MD 20852. 

Contact Person: Joyce C. Pegues, Ph.D., 

Scientific Review Officer, Special Review 

and Logistics Branch, Division of Extramural 

Activities, NIH National Cancer Institute, 

NIH, 6116 Executive Boulevard, Room 7149, 

Bethesda, MD 20892–8329, 301–594–1286, 

peguesj@mail.nih.gov. 

Information is also available on the 

Institute’s/Center’s home page: http:// 

deainfo.nci.nih.gov/advisory/sep/sep.htm, 

where an agenda and any additional 

information for the meeting will be posted 

when available. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.392, Cancer Construction; 

93.393, Cancer Cause and Prevention 

Research; 93.394, Cancer Detection and 

Diagnosis Research; 93.395, Cancer 

Treatment Research; 93.396, Cancer Biology 

Research; 93.397, Cancer Centers Support; 

93.398, Cancer Research Manpower; 93.399, 

Cancer Control, National Institutes of Health, 

HHS) 

Dated: April 19, 2012. 

Jennifer S. Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2012–10079 Filed 4–25–12; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Mental Health; 

Notice of Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The contract proposals and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the contract 

proposals, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Mental Health Special Emphasis Panel; Fast 

Fail—Experimental Medicines Contracts— 

Mood and Anxiety Disorders. 

Date: May 22, 2012. 

Time: 1 p.m. to 6 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: National Institutes of Health, 

Neuroscience Center, 6001 Executive 

Boulevard, Rockville, MD 20852, (Telephone 

Conference Call). 

Contact Person: David I. Sommers, Ph.D., 

Scientific Review Officer, Division of 

Extramural Activities, National Institute of 

Mental Health, National Institutes of Health, 

6001 Executive Blvd., Room 6154, MSC 9606, 

Bethesda, MD 20892–9606, 301–443–7861, 

dsommers@mail.nih.gov. 

Name of Committee: National Institute of 

Mental Health Special Emphasis Panel; Fast 

Fail—Experimental Medicines Contracts— 

Autism. 

Date: May 24, 2012. 

Time: 1 p.m. to 6 p.m. 

Agenda: To review and evaluate contract 

proposals 

Place: National Institutes of Health, 

Neuroscience Center, 6001 Executive 

Boulevard, Rockville, MD 20852, (Telephone 

Conference Call). 

Contact Person: David I. Sommers, Ph.D., 

Scientific Review Officer, Division of 

Extramural Activities, National Institute of 

Mental Health, National Institutes of Health, 

6001 Executive Blvd., Room 6154, MSC 9606, 

Bethesda, MD 20892–9606, 301–443–7861, 

dsommers@mail.nih.gov. 

Name of Committee: National Institute of 

Mental Health Special Emphasis Panel; Fast 

Fail—Experimental Medicines Contracts— 

Psychotic Spectrum. 

Date: May 25, 2012. 

Time: 1 p.m. to 6 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: National Institutes of Health, 

Neuroscience Center, 6001 Executive 


tkelley on DSK3SPTVN1PROD with NOTICES
Federal Register / Vol. 77, No. 81 / Thursday, April 26, 2012 / Notices 24971 

Boulevard, Rockville, MD 20852, (Telephone 

Conference Call). 

Contact Person: David I. Sommers, Ph.D., 

Scientific Review Officer, Division of 

Extramural Activities, National Institute of 

Mental Health, National Institutes of Health, 

6001 Executive Blvd., Room 6154, MSC 9606, 

Bethesda, MD 20892–9606, 301–443–7861, 

dsommers@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.242, Mental Health Research 

Grants; 93.281, Scientist Development 

Award, Scientist Development Award for 

Clinicians, and Research Scientist Award; 

93.282, Mental Health National Research 

Service Awards for Research Training, 

National Institutes of Health, HHS) 

Dated: April 18, 2012. 

Jennifer S. Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2012–10140 Filed 4–25–12; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Center for Complementary & 

Alternative Medicine; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Center for 

Complementary and Alternative Medicine 

Special Emphasis Panel; Education, 

conferences, training. 

Date: June 22, 2012. 

Time: 8 a.m. to 7 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Marriott Courtyard Gaithersburg 

Washingtonian Ctr, 204 Boardwalk Place, 

Gaithersburg, MD 20878. 

Contact Person: Peter Kozel, Ph.D., 

Scientific Review Officer, NCCAM, 6707 

Democracy Boulevard, Suite 401, Bethesda, 

MD 20892–5475, 301–496–8004, 

kozelp@mail.nih.gov. 

Name of Committee: National Center for 

Complementary and Alternative Medicine 

Special Emphasis Panel; Natural products 

RFA. 

Date: July 19–20, 2012. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Bethesda North Marriott Hotel & 

Conference Center, 5701 Marinelli Road, 

Bethesda, MD 20852. 

Contact Person: Martina Schmidt, Ph.D., 

Scientific Review Officer, Office of Scientific 

Review, National Center for Complementary 

& Alternative Medicine, NIH, 6707 

Democracy Blvd., Suite 401, Bethesda, MD 

20892, 301–594–3456, 

schmidma@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.213, Research and Training 

in Complementary and Alternative Medicine, 

National Institutes of Health, HHS) 

Dated: April 20, 2012. 

Jennifer S. Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2012–10127 Filed 4–25–12; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Neurological 

Disorders and Stroke; Notice of Closed 

Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable materials, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Neurological Disorders and Stroke Initial 

Review Group; Neurological Sciences and 

Disorders C. 

Date: June 18–19, 2012 

Time: 8 a.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Mayflower Park Hotel, 405 Olive 

Way, Seattle, WA 98101. 

Contact Person: William C. Benzing, Ph.D., 

Scientific Review Officer, Scientific Review 

Branch, Division of Extramural Research, 

NINDS, NIH, NSC, 6001 Executive Blvd., 

Suite 3204, MSC 9529, Bethesda, MD 20892– 

9529, 301–496–0660, 

Benzingw@mail.nih.gov. 

Name of Committee: Neurological Sciences 

Training Initial Review Group; NST–2 

Subcommittee. 

Date: June 25–26, 2012. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: The Fairmont Washington, DC, 2401 

M Street NW., Washington, DC 20037. 

Contact Person: JoAnn McConnell, Ph.D., 

Scientific Review Officer, Scientific Review 

Branch, Division of Extramural Research, 

NINDS, NIH, NSC, 6001 Executive Blvd., 

Suite 3208, MSC 9529, Bethesda, MD 20892– 

9529, 301–496–5324, 

McConnej@ninds.nih.gov. 

Name of Committee: National Institute of 

Neurological Disorders and Stroke Initial 

Review Group; Neurological Sciences and 

Disorders A. 

Date: June 27–28, 2012. 

Time: 8 a.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Churchill Hotel, 1914 Connecticut 

Avenue NW., Washington, DC 20009. 

Contact Person: Richard D. Crosland, 

Ph.D., Scientific Review Officer, Scientific 

Review Branch, Division of Extramural 

Research, NINDS, NIH, NSC, 6001 Executive 

Blvd., Suite 3208, MSC 9529, Bethesda, MD 

20892–9529, 301–496–5324, 

McConnej@ninds.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.853, Clinical Research 

Related to Neurological Disorders; 93.854, 

Biological Basis Research in the 

Neurosciences, National Institutes of Health, 

HHS) 

Dated: April 20, 2012. 

Jennifer S. Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2012–10126 Filed 4–25–12; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Deafness and 

Other Communication Disorders; 

Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute on 

Deafness and Other Communication 


tkelley on DSK3SPTVN1PROD with NOTICES